Sci Rep
The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong Road, Nanning, 530021, Guangxi, People's Republic of China.
Published: March 2025
We determined the relationship between ferroptosis and immune cells in ankylosing spondylitis and the role of the Chinese herbal medicine Cassia twigs in treating ankylosing spondylitis. We analyzed clinical data on ankylosing spondylitis, transcriptome data, single-cell sequencing data, and genes related to ferroptosis and Cassia twigs. Clinical variables related to AS were selected through logistic regression analysis of the clinical data combined with machine learning. GSEA and enrichment analysis were performed on genes related to ferroptosis, combined with transcriptome data and drug-related genes, to identify the key genes and drug targets related to AS, as well as, the key immune cells. Then, the single-cell data and cell subtypes were analyzed. Finally, the interconnections between immune cells were analyzed through intercellular communication. Five variables, including neutrophils, were screened for clinical data analysis. The AUC of the experimental group was 0.859 and that of the validation group was 0.807. Ferroptosis gene NFE2L2 was identified as the final drug target of AS; it was upregulated in AS and downregulated in the control group by immunohistochemical verification, both of which were statistically significant (P < 0.001). Neutrophils were divided into two subgroups: high expression of NFE2L2 and low expression of NFE2L2. Through molecular docking, Cassia twigs were found to effectively act on the ferroptosis gene NFE2L2. Neutrophils act as important immune cells in AS. The twigs of the Chinese herb Cassia can treat AS by acting on the protein structure of the ferroptosis gene NFE2L2.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/s41598-025-88775-x | DOI Listing |
Ther Adv Musculoskelet Dis
March 2025
Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Charité-Universitätsmedizin Berlin, Berlin, Germany.
Background: Early treatment initiation is one of the strongest predictors of good treatment response in axial spondyloarthritis (axSpA). Recently, the Assessment in SpondyloArthritis International Society (ASAS) defined early axSpA as a diagnosis of axSpA with a duration of axial symptoms equal to or less than 2 years. Tofacitinib is a Janus kinase (JAK) inhibitor for the treatment of ankylosing spondylitis.
View Article and Find Full Text PDFIntroduction: Renal complications are frequently observed in patients with ankylosing spondylitis (AS), with IgA nephropathy (IgAN) being a particularly significant concern. Although anecdotal evidence suggests a potential association between AS and IgAN, robust epidemiological data remain limited. Previous studies have reported varying prevalence rates of IgAN among AS patients, but these studies are often constrained by small sample sizes and inconsistent methodologies.
View Article and Find Full Text PDFSemin Arthritis Rheum
March 2025
Rheumatology Department, Reina Sofia University Hospital, 14005 Córdoba, Spain; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), 14005 Córdoba, Spain; Medical and Surgical Sciences Department, University of Cordoba, 14005 Córdoba, Spain.
Objective: This study aimed to evaluate the association of cervical and lumbar mobility with functional ability in patients with axial spondyloarthritis (axSpA) using an inertial measurement unit (IMU) sensor system, as well as the influence of disease duration on this association.
Methods: This cross-sectional study included 156 patients with axSpA from the Córdoba axSpA Task Force Registry and Outcomes (CASTRO) registry. Spinal mobility was assessed with the IMU system and functional ability was measured using the Bath Ankylosing Spondylitis Functional Index (BASFI).
Mol Biotechnol
March 2025
The Third Clinical Medicine College, Ningxia Medical University (People's Hospital of Ningxia Hui Autonomous Region), Yinchuan, 750002, China.
The activity of Wnt inhibitory factor 1 (WIF1) is reduced upon promoter methylation and is involved in cartilage degradation in osteoarthritis. This study aims to investigate the mechanism by which WIF1 methylation is involved in chondrocyte damage in ankylosing spondylitis (AS). A model of chondrocyte inflammatory injury in AS was constructed by stimulation with interleukin (IL)-17.
View Article and Find Full Text PDFMedicine (Baltimore)
March 2025
Department of Orthopedics, Shenzhen Second People's Hospital/First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
Musculoskeletal diseases are the leading cause of disability-adjusted life years. Mitochondria, often referred to as the "powerhouses" of cells, are believed to play a role in regulating cellular metabolism and differentiation, potentially influencing the occurrence and progression of musculoskeletal diseases. However, the exact causal relationships remain to be defined.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.